SINOVAC’s product portfolio includes vaccines against COVID-19, enterovirus 71 (EV71) infected hand-foot-mouth disease (HFMD), hepatitis A, varicella, influenza, poliomyelitis, pneumococcal ...
SINOVAC’s product portfolio includes vaccines against COVID-19, enterovirus 71 (EV71) infected hand-foot-mouth disease (HFMD), hepatitis A, varicella, influenza, poliomyelitis, pneumococcal disease, ...
BEIJING - Sinovac Biotech Ltd. (NASDAQ ... including CoronaVac® for COVID-19 and vaccines for hepatitis A, EV71, and influenza, has received global recognition with approvals in over 60 countries ...
People fully vaccinated against hepatitis B who are not immunocompromised can expect sustained immunity throughout their ...
B, a new hepatitis vaccine, vs. standard hepatitis B vaccines as a booster in previously vaccinated individuals.
The hepatitis A virus (HAV) is one of the main causes of viral hepatitis and is responsible for an estimated 159,000 ...
Still, a bout of hepatitis A can last weeks or months, and the worst cases can cause liver damage and even death. Since 1995, ...